104 related articles for article (PubMed ID: 25322343)
21. Characterization of human melanoma cell lines and melanocytes by proteome analysis.
Caputo E; Maiorana L; Vasta V; Pezzino FM; Sunkara S; Wynne K; Elia G; Marincola FM; McCubrey JA; Libra M; Travali S; Kane M
Cell Cycle; 2011 Sep; 10(17):2924-36. PubMed ID: 21857157
[TBL] [Abstract][Full Text] [Related]
22. Identification and functional characterization of ASK/Dbf4, a novel cell survival gene in cutaneous melanoma with prognostic relevance.
Nambiar S; Mirmohammadsadegh A; Hassan M; Mota R; Marini A; Alaoui A; Tannapfel A; Hegemann JH; Hengge UR
Carcinogenesis; 2007 Dec; 28(12):2501-10. PubMed ID: 17768177
[TBL] [Abstract][Full Text] [Related]
23. Expression patterns of S100 proteins in melanocytes and melanocytic lesions.
Petersson S; Shubbar E; Enerbäck L; Enerbäck C
Melanoma Res; 2009 Aug; 19(4):215-25. PubMed ID: 19521263
[TBL] [Abstract][Full Text] [Related]
24. Mass Spectrometry-Based Proteomic Characterization of Cutaneous Melanoma Ectosomes Reveals the Presence of Cancer-Related Molecules.
Surman M; Kędracka-Krok S; Hoja-Łukowicz D; Jankowska U; Drożdż A; Stępień EŁ; Przybyło M
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331267
[TBL] [Abstract][Full Text] [Related]
25. Gene expression patterns in melanocytic cells: candidate markers for early stage and malignant transformation.
Meije CB; Hakvoort TB; Swart GW; Westerhof W; Lamers WH; Das PK
J Pathol; 2002 Jan; 196(1):51-8. PubMed ID: 11748642
[TBL] [Abstract][Full Text] [Related]
26. The contribution of proteomics to the identification of biomarkers for cutaneous malignant melanoma.
Bougnoux AC; Solassol J
Clin Biochem; 2013 Apr; 46(6):518-23. PubMed ID: 23262402
[TBL] [Abstract][Full Text] [Related]
27. Nestin expression in cutaneous melanomas and melanocytic nevi.
Brychtova S; Fiuraskova M; Hlobilková A; Brychta T; Hirnak J
J Cutan Pathol; 2007 May; 34(5):370-5. PubMed ID: 17448190
[TBL] [Abstract][Full Text] [Related]
28. Feasibility study on measuring selected proteins in malignant melanoma tissue by SRM quantification.
Welinder C; Jönsson G; Ingvar C; Lundgren L; Baldetorp B; Olsson H; Breslin T; Rezeli M; Jansson B; Laurell T; Fehniger TE; Wieslander E; Pawlowski K; Marko-Varga G
J Proteome Res; 2014 Mar; 13(3):1315-26. PubMed ID: 24490776
[TBL] [Abstract][Full Text] [Related]
29. Application of the SILAC (stable isotope labelling with amino acids in cell culture) technique in quantitative comparisons for tissue proteome expression.
Xu Y; Liang S; Shen G; Xu X; Liu Q; Xu Z; Gong F; Tang M; Wei Y
Biotechnol Appl Biochem; 2009 Jul; 54(1):11-20. PubMed ID: 19250064
[TBL] [Abstract][Full Text] [Related]
30. Direct tissue proteomics in human diseases: potential applications to melanoma research.
Rezaul K; Wilson LL; Han DK
Expert Rev Proteomics; 2008 Jun; 5(3):405-12. PubMed ID: 18532908
[TBL] [Abstract][Full Text] [Related]
31. A protein deep sequencing evaluation of metastatic melanoma tissues.
Welinder C; Pawłowski K; Sugihara Y; Yakovleva M; Jönsson G; Ingvar C; Lundgren L; Baldetorp B; Olsson H; Rezeli M; Jansson B; Laurell T; Fehniger T; Döme B; Malm J; Wieslander E; Nishimura T; Marko-Varga G
PLoS One; 2015; 10(4):e0123661. PubMed ID: 25874936
[TBL] [Abstract][Full Text] [Related]
32. Cell adhesion and communication proteins are differentially expressed in melanoma progression model.
Rezze GG; Fregnani JH; Duprat J; Landman G
Hum Pathol; 2011 Mar; 42(3):409-18. PubMed ID: 21193224
[TBL] [Abstract][Full Text] [Related]
33. Proteomic analysis of uveal melanoma reveals novel potential markers involved in tumor progression.
Zuidervaart W; Hensbergen PJ; Wong MC; Deelder AM; Tensen CP; Jager MJ; Gruis NA
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):786-93. PubMed ID: 16505008
[TBL] [Abstract][Full Text] [Related]
34. Comparative proteomic analysis reveals unique tumor protein composition among the melanoma subtypes pure desmoplastic and superficial spreading.
Schowalter MK; Dulmage BO; Ho J; Vu JR; Falo LD; Geskin LJ
Melanoma Res; 2014 Aug; 24(4):397-400. PubMed ID: 24743055
[TBL] [Abstract][Full Text] [Related]
35. Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases.
de Almeida LS; Requena L; Rütten A; Kutzner H; Garbe C; Pestana D; Gomes MM
Am J Dermatopathol; 2008 Jun; 30(3):207-15. PubMed ID: 18496419
[TBL] [Abstract][Full Text] [Related]
36. Dipeptidyl peptidase II is not a marker for progression in melanoma.
Fröhlich E; Maier E; Mack AF; Garbe C
J Dermatol Sci; 2009 Jan; 53(1):68-71. PubMed ID: 18823758
[No Abstract] [Full Text] [Related]
37. Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas.
Vogt T; Stolz W; Welsh J; Jung B; Kerbel RS; Kobayashi H; Landthaler M; McClelland M
Clin Cancer Res; 1998 Mar; 4(3):791-7. PubMed ID: 9533549
[TBL] [Abstract][Full Text] [Related]
38. Protein B61 as a new growth factor: expression of B61 and up-regulation of its receptor epithelial cell kinase during melanoma progression.
Easty DJ; Guthrie BA; Maung K; Farr CJ; Lindberg RA; Toso RJ; Herlyn M; Bennett DC
Cancer Res; 1995 Jun; 55(12):2528-32. PubMed ID: 7780963
[TBL] [Abstract][Full Text] [Related]
39. Affinity proteomics led identification of vimentin as a potential biomarker in colon cancers: insights from serological screening and computational modelling.
Bukhari S; Mokhdomi TA; Chikan NA; Amin A; Qazi H; Wani SH; Wafai AH; Tyub S; Mustafa F; Mir MS; Chowdri NA; Qadri RA
Mol Biosyst; 2015 Jan; 11(1):159-69. PubMed ID: 25319351
[TBL] [Abstract][Full Text] [Related]
40. Survivin protein in UVB induced apoptosis of melanoma cells and in melanoma progression.
Zhang H
Oncol Rep; 2005 Jun; 13(6):1121-6. PubMed ID: 15870931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
